Retransplantation in patients with graft loss caused by polyoma virus nephropathy

Emilio Ramos, Flavio Vincenti, Wei X. Lu, Ron Shapiro, Jennifer Trofe, Robert J. Stratta, Johann Jonsson, Parmjeet S. Randhawa, Cinthia B. Drachenberg, John C. Papadimitriou, Matthew R. Weir, Ravinder K. Wali

Research output: Contribution to journalArticlepeer-review

86 Scopus citations


The characteristics and outcome in 10 patients who underwent retransplantation after losing their renal grafts to BK virus-associated nephropathy (BKAN) are described. The patients underwent retransplantation at a mean of 13.3 months after failure of the first graft. Nephroureterectomy of the first graft was performed in seven patients. Maintenance immunosuppression regimens after the first and second grafts were similar, consisting of a combination of a calcineurin inhibitor, mycophenolate mofetil, and prednisone. BKAN recurred in one patient 8 months after retransplantation, but stabilization of graft function was achieved with a decrease in immunosuppression and treatment with low-dose cidofovir. After a mean follow-up of 34.6 months, all patients were found to have good graft function with a mean creatinine of 1.5 mg/dL. From this collective experience from five transplant centers (although the follow-up after retransplantation was not extensive), it can be concluded that patients with graft loss caused by BKAN can safely undergo retransplantation. The risk of recurrence does not seem to be increased in comparison with the first graft.

Original languageEnglish
Pages (from-to)131-133
Number of pages3
Issue number1
StatePublished - 15 Jan 2004
Externally publishedYes


Dive into the research topics of 'Retransplantation in patients with graft loss caused by polyoma virus nephropathy'. Together they form a unique fingerprint.

Cite this